Mr Peter Collins
Ipsos, London (United Kingdom of Great Britain & Northern Ireland)
Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4
Event: ESC Congress 2024
Topic: Infiltrative Myocardial Disease
Session: The different faces of cardiac amyloidosis
